Both in Pharmaceuticals
Aptevo Therapeutics vs Revelation Biosciences
Over the past year APVO returned −94.6% and REVB returned −86.6%; their daily moves had a correlation of 0.02.
APVO −94.6% REVB −86.6%Growth of $1, one year, split-adjusted
| Metric | APVO | REVB |
|---|---|---|
| Price | $1.37 | $4.12 |
| Market cap | $2.5M | $2.3M |
| Today | +0.74% | −7.05% |
| 1 month | −23.7% | −21.8% |
| 6 months | −72.3% | −42.3% |
| Year to date | −85.5% | −81.6% |
| 1 year | −94.8% | −87.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.8M | $11.5M |
| Dividend yield | — | — |
| Volatility (60d) | 112.4% | 552.1% |
| Short % of float | 5.8% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).